Table 2.
Cell line | ||||||||
---|---|---|---|---|---|---|---|---|
TOV-21G | SKOV-3 | |||||||
miRNA selected | Predicted targets related to apoptosis | Prediction Database | Validation Database | Taqman Assay ID | Log2(FC)** | Interpretation | Log2(FC) | Interpretation |
hsa-miR-150-5p | TP53, AIFM2 | TargetScan, miRanda | miRTarBase | 000473 | −0.003 | *Sub expressed (p < 0.01) |
−4.094 | *Sub expressed (p < 0.01) |
hsa-miR-181a | DDX3X, BCL2 | TargetScan, miRanda | TARBASE (DianaTools) | 002317 | −2.932 | p = 0.498 | −3.580 | *Sub expressed (p < 0.01) |
hsa-miR-340-5p | DDX5, BCL2L2 | TargetScan | TARBASE (DianaTools) | 002258 | −1.797 | *Sub expressed (p < 0.01) |
−4.645 | *Sub expressed (p < 0.01) |
hsa-miR-128 | ACIN1, AFF1 | TargetScan, | miRTarBase | 002216 | −3.777 | *Sub expressed (p < 0.01) |
−5.090 | *Sub expressed (p < 0.01) |
hsa-miR-125b-5p | BAK1, BCL2 | TargetScan | TARBASE (DianaTools) | 000449 | −1.999 | *Sub expressed (p < 0.01) |
−7.722 | *Sub expressed (p < 0.01) |
hsa-miR-26a | BID, THAP5 | TargetScan | TARBASE (DianaTools) | 002443 | 0.558 | p = 0.502 | −2.866 | *Sub expressed (p < 0.01) |
hsa-miR-181c | BCL2, BCL2L11 | TargetScan, miRanda | miRTarBase | 000482 | 1.426 | p = 0.502 | 0.445 | *Superexpressed (p < 0.01) |
hsa-miR-20a | BCL2, BCL2L11, THAP1 | TargetScan | TARBASE (DianaTools) | 000580 | −2.056 | *Sub expressed (p < 0.01) |
−4.792 | *Sub expressed (p < 0.01) |
hsa-miR-221 | BMF, APAF1 | TargetScan | miRTarBase | 000524 | −0.746 | p = 0.498 | −9.155 | *Sub expressed (p < 0.01) |
hsa-miR-17-5p | CAAP1, CASP8, AREL1 | MirTarget2 | – | 002308 | −0.795 | *Sub expressed (p < 0.01) |
−14.744 | *Sub expressed (p < 0.01) |
hsa-miR-4478 | APAF1, TNFRSF10C, TNFRSF10B | MirTarget2 | – | 465302_mat | −1.636 | *Sub expressed (p < 0.01) |
−5.974 | *Sub expressed (p < 0.01) |
Software: REST 2009 (Qiagen). *Significantly different (α = 5%), comparing tumorspheres to monolayer model, n = 2
**Fold Change (FC) = (2–ΔΔCq)